As new variants of the SARS-CoV-2 virus emerge, it is imperative that novel, active therap...

Regdanvimab—A New Attack of the (Mono)Clones – Contagionlive.com

As new variants of the SARS-CoV-2 virus emerge, it is imperative that novel, active therapeutics are available for treatment or prevention. Regdanvimab (CT-P59) is a neutralizing antibody that was studied in a phase 2/3 trial (NCT04602000) in…

 

Read the full article here


-- END RSP MOD -->